Close Menu

NEW YORK (360Dx) – Chembio Diagnostics announced today that preliminary estimates show its fourth quarter 2018 revenues increased by between 22 percent and 27 percent over the prior-year quarter.

For the three months ended Dec. 31, 2018, the firm reported preliminary revenues of between $7.3 million and $7.6 million.

Chembio, which has a focus on infectious disease diagnostics, said its preliminary revenues for 2018 were between $33.1 million and $33.4 million, an increase of about 38 percent to 39 percent compared to the full-year 2017. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.